Integrated Program in Biomedical Sciences

Molecular Therapeutics and Cell Signaling

Rennolds S. Ostrom, Ph.D.

The molecular therapeutics and cell signaling track provide a broad training in pharmacology, molecular biology, and cell signaling. The research interests of the faculty in the molecular therapeutic track include neuropharmacology, behavorial neuroscience, cancer pharmacology and drug development, cardiovascular pharmacology, and cell signaling and the regulation of gene expression. The molecular therapeutics and cell signaling track is uniquely positioned to integrate pharmacologic and molecular approaches to problems in addiction, cancer therapeutics, cardiovascular disease, cell signaling, and regulation of channels. The general areas covered in our track are listed below:

· Drug Targets and Disease
· Pharmacology
· Receptor Kinetics and Structure
· Signal Transduction
· Transcriptional Regulation

* Faculty and Their Research Interests
* Electives
* Students
* Cardiovascular/Lipoprotein Training Grant
* Center of Excellence in Neurobiology and Imaging of Brain Disease

• Cancer Biology and Developmental Biology
• Cell Biology and Biochemistry
• Genetics, Functional Genomics, and Proteomics
• Molecular, Cellular, and Systems Physiology
• Microbial Pathogenesis, Immunology, and Inflammation
• Molecular Therapeutics and Cell Signaling
• Neuroscience

Revised 15 November 2007